| Structure |
Chemical Name |
CAS |
MF |
 |
Trelagliptin Impurity 1 |
1821400-07-0 |
C21H13ClF2N4O2 |
 |
Vortioxetine Imp.J |
2137588-68-0 |
C18H22N2S |
 |
4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
1608459-56-8 |
C18H27N3O3 |
 |
4,5-dichloro Rivaroxaban |
2305917-61-5 |
C25H28ClN3O6S |
 |
Solifenacin EP Impurity B |
1534326-81-2 |
C31H28N2O |
 |
Vildagliptin Impurity 6 |
1846606-31-2 |
C17H23N3O2 |
 |
Flucloxacillin Impurity A |
|
|
 |
Nicorandil Impurity 1 |
|
|
 |
Piperacillin Impurity 6 |
|
|
 |
Bosutinib Impurity 5 |
1391063-17-4 |
C26H29Cl2N5O3 |
 |
Levomilnacipran impurity |
|
|
 |
Sofosbuvir IMpurity 4 |
|
|
 |
1,3-bis(4-isobutylphenyl)butan-1-one |
|
C24H32O |
 |
6-isobutyl-3-methyl-2,3-dihydro-1H-inden-1-one |
1340024-54-5 |
C14H18O |
 |
2-(2-ピリジニルアミノ)グリオキシル酸エチル |
41374-72-5 |
C9H10N2O3 |
 |
Canagliflozin Impurity 18 |
|
|
 |
Canagliflozin Impurity 23 |
|
|
 |
Carfilzomib Impurity 4 |
|
|
 |
Lenvatinib Impurity 2 |
2380197-90-8 |
C28H22ClN5O5 |
 |
FeBuxostat Impurity 33 |
100118-38-5 |
C12H14O5 |
 |
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
C22H22N6O |
 |
Latamoxef Impurity 1 |
75007-70-4 |
C19H20N6O7S |
 |
Amlodipine iMpurity K |
1809326-44-0 |
C18H21ClN2O5 |
 |
Cabozantinib impurity 4 |
95932-39-1 |
C11H15NO3 |
 |
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H27FN3NaO6S |
 |
4-(フェニルアミノ)-6,7-ビス(2-メトキシエトキシ)キナゾリン |
1145671-52-8 |
C20H23N3O4 |
 |
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
 |
4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
941296-96-4 |
C16H28N2O4 |
 |
(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid |
|
C8H8FN3O4S |
 |
Amlodipine Impurity 10 |
2170104-51-3 |
C26H31ClN2O8S |
 |
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
 |
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
 |
Dapagliflozin Open Ring |
2100872-88-4 |
C21H27ClO7 |
 |
Rortezide impurity |
|
|
 |
Cabozantinib Impurity A |
|
|
 |
Loxoprofen Impurity E |
|
|
 |
(R)-4-Propylpyrrolidin-2-one |
930123-37-8 |
C7H13NO |
 |
Rocuronium Bromide Intermediate B Impurity E-1 |
1190105-60-2 |
C29H48N2O3 |
 |
4-Chloro-2-propylsulfanyl-pyrimidine |
1351990-36-7 |
C7H9ClN2S |
 |
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate |
1194550-67-8 |
C36H30Cl2N2O7S |
![D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]-](/CAS/20180528/GIF/119238-52-7.gif) |
D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]- |
119238-52-7 |
C9H15NO3S |
![2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI)](/CAS/20200119/GIF/145281-92-1.gif) |
2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI) |
145281-92-1 |
C8H9FN2O4S |
![Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]-](/CAS/20180529/GIF/15026-80-9.gif) |
Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]- |
15026-80-9 |
C11H19NO3 |
 |
L-Phenylalanine, N-L-leucyl-, methyl ester |
38155-18-9 |
C16H24N2O3 |
![Ethanol, 2-[(2-chloroethyl)amino]-](/CAS/20180529/GIF/3890-98-0.gif) |
Ethanol, 2-[(2-chloroethyl)amino]- |
3890-98-0 |
C4H10ClNO |
![2-[(2-フリルメチル)アミノ]-5-スルファモイル安息香酸](/CAS/20180531/GIF/4818-85-3.gif) |
2-[(2-フリルメチル)アミノ]-5-スルファモイル安息香酸 |
4818-85-3 |
C12H12N2O5S |
 |
2H-1,3-ベンゾジオキソール-4-オール |
69393-72-2 |
C7H6O3 |
 |
1H-Benzimidazole, 6-bromo-2-methyl-4-(phenylmethoxy)- |
774582-60-4 |
C15H13BrN2O |
 |
2-Diethylamino-N-(2,5-dimethyl-phenyl)-acetamide |
857570-37-7 |
C14H22N2O |
 |
(S)‐1‐ベンジル‐3‐N‐BOC‐アミノピペリジン |
216854-24-9 |
C17H26N2O2 |
 |
(Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
1987887-92-2 |
C24H21N3O3 |
![1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one](/CAS/20180527/GIF/1971858-36-2.gif) |
1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one |
1971858-36-2 |
C23H25F3N4O |
![2-[3-(メチルアミノ)-1-(チオフェン-2-イル)プロピル]ナフタレン-1-オール](/CAS/20180527/GIF/1033803-59-6.gif) |
2-[3-(メチルアミノ)-1-(チオフェン-2-イル)プロピル]ナフタレン-1-オール |
1033803-59-6 |
C18H19NOS |
 |
Bendamustine Desmethyl Impurity |
41515-13-3 |
C15H19Cl2N3O2 |
 |
(R)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine |
878757-08-5 |
C19H21NOS |
 |
Capecitabine Impurity 10 |
|
|
 |
Carfilzomib Impurity C |
|
|
 |
Cefathiamidine Impurity 4 |
1418224-75-5 |
C10H11BrN2O5S |
 |
Cefodizime Impurity 2 |
|
|
 |
Choline Fenofibrate Impurity 1 |
2985-79-7 |
C13H9ClO2 |
 |
DecitaBine Impurity 11 |
|
|
 |
Isavuconazole Impurity 21 |
3094994-76-7 |
C13H14F2N4OS |
 |
Isavuconazole Impurity 27 |
|
|
 |
Istradefylline Impurity E |
|
|
 |
Linagliptin Impurity 41 |
|
|
 |
PalBociclib Impurity 17 |
|
|
 |
PalBociclib Impurity 24 |
|
|
 |
Posaconazole Impurity 12 |
|
|
 |
Posaconazole Impurity 24 |
165115-78-6 |
C19H20F2O2 |
 |
Sitagliptin Impurity 24 |
2349567-54-8 |
C15H19F2NO4 |
 |
Tamoxifen EP Impurity H |
809285-09-4 |
C43H48N2O2 |
 |
Trelagliptin Impurity 20 |
1821520-42-6 |
C20H22FN5O3 |
 |
Umeclidinium Impurity 3 |
869113-45-1 |
C29H32BrNO3 |
 |
Vardenafil Impurity 7 |
448184-56-3 |
C21H26N6O7S |
 |
Moxifloxacin Related Compound A (HCl salt form) |
151282-23-4 |
C20H22ClF2N3O3 |
![1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)-](/CAS/20180527/GIF/1404559-22-3.gif) |
1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)- |
1404559-22-3 |
C27H38N6O3S |
 |
Ampicillin Impurity A |
|
|
 |
Oxacillin Sodium Impurity B(EP) |
|
|
 |
3,5-dichlorothiophene-2-carboxylic acid |
89166-94-9 |
C5H2Cl2O2S |
 |
Brexpiprazole Impurity 2 |
2094559-58-5 |
C38H40N4O4S |
![2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid](/CAS/20180527/GIF/80047-38-7.gif) |
2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid |
80047-38-7 |
C12H10N2O3 |
 |
Levofloxacin Impurity 7 |
1607796-83-7 |
C15H14FNO5 |
 |
Moxifloxacin EP Impurity E HCl |
|
|
 |
Pantoprazole Impurity 11 |
172282-50-7 |
C7H8F2N2O |
 |
Solifenacin Related Compound 24 |
1682642-69-8 |
C15H23ClN2 |
 |
Ticagrelor Related Compound 44 |
1431867-40-1 |
C8H12ClN3OS |
 |
(trans)-2-(3,4-difluorophenyl)cyclopropanecarboxamide |
1006614-51-2 |
C10H9F2NO |
 |
2-cyano-N-methyl-N-((3R,4R)-4-methyl piperidin-3-yl) Acetamide hydrochloride |
1640971-87-4 |
C10H18ClN3O |
 |
6-methyl-N1-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
|
C17H17N5 |
 |
WPDCFRNNHUYQGW-IUXPMGMMSA-N |
1628639-06-4 |
C21H23NO4 |
 |
tert-Butyl 2-((4S,6S)-6-(chloromethyl(02,2-1,3-dioxan-4-yl)acetate |
521974-00-5 |
C13H23ClO4 |
 |
Cefadroxil Sulfoxide |
182290-77-3 |
C16H17N3O6S |
 |
GSFIWDGFHNAUFU-UHFFFAOYSA-N |
2125702-80-7 |
C16H29N5O4 |
 |
2,5-dichloro-N,N-dimethylbenzamide |
90526-01-5 |
C9H9Cl2NO |
 |
Ibrutinib Impurity 9 |
2068022-09-1 |
C25H21D5N6O4 |
 |
4-クロロ-3-ヒドロキシブチロニトリル |
105-33-9 |
C4H6ClNO |
 |
(Z)-2-propylhept-2-enal |
95667-14-4 |
C10H18O |
 |
(R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-BUTYRIC ACID-HCL |
1335470-16-0 |
C10H11F2NO2 |
 |
4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl |
2176485-21-3 |
C30H28Cl2O2 |
 |
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide |
294852-91-8 |
C18H22N2O |